Price target
39.530.000.00%
The 8 analysts offering 1 year price forecasts for NKB2 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 9 analysts giving stock ratings to NKB2 in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
NKB2 EPS for the last quarter is 0.02 EUR despite the estimation of 0.03 EUR. In the next quarter EPS is expected to reach 0.14 EUR. Track more of TG THERAPEUTICS INC financials and stay on top of what is up with the company.
In the next quarter TG THERAPEUTICS INC revenue is expected to reach 105.59 M EUR. Check out TG THERAPEUTICS INC revenue and earnings and make informed decisions.
According to analysts, NKB2 price target is 39.53 EUR with a max estimate of 53.19 EUR and a min estimate of 9.67 EUR. Check if this forecast comes true in a year, meanwhile watch TG THERAPEUTICS INC stock price chart and keep track of the current situation with NKB2 news and stock market news.
We've gathered opinions of 9 analysts rating NKB2 stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.